| Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases. | |
| | |
MedLine Citation:
|
PMID: 19943211 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 39th Annual Meeting of the Society for Neuroscience (SFN), held in Chicago, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on novel neuroprotective and antiparkinsonian agents, and compounds in development for the treatment of dementia, schizophrenia, depression, obesity and spinal muscular atrophy. Investigational drugs discussed include velusetrag and TD-8954 (both from Theravance Inc), SEP-228791 and SEP-226330 (both from Sepracor Inc), ADL-5510 (Adolor Corp), PF-217830 (Pfizer Inc), KB-099520 (Karo Bio AB), tesofensine (NeuroSearch A/S) and TRP6-01 (Theraptosis). |
| | |
Authors:
|
Asma Al-Shamahi; Konrad Kirkham; Livia Hookes |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 12 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-11-27 Completed Date: 2010-01-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 734-7 Citation Subset: IM |
Affiliation:
|
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. asma.al-shamahi@thomsonreuters.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Central Nervous System Agents / pharmacology*, therapeutic use Central Nervous System Diseases / drug therapy*, physiopathology Drug Design Drugs, Investigational / pharmacology, therapeutic use Humans Neurodegenerative Diseases / drug therapy*, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Central Nervous System Agents; 0/Drugs, Investigational |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS di...
Next Document: World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.